search
Back to results

Behavioral Therapy in Patients With Rumination

Primary Purpose

Functional Gastrointestinal Disorders

Status
Recruiting
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Behavioral therapy
Physiotherapy
Sponsored by
Helsinki University Central Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Functional Gastrointestinal Disorders

Eligibility Criteria

15 Years - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Rome IV criteria for rumination syndrome fulfilled
  • gastroscopy, esophageal HR-manometry and 24-hour pH-impedance monitoring performed before referral to study

Exclusion Criteria:

  • eating disorder, BMI <14, pregnancy, cognitive or other disorder that disallows behavioral therapy

Sites / Locations

  • Helsinki University Central HospitalRecruiting
  • Helsinki University Hospital, Childrens' HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Behavioral therapy

Arm Description

Behavioral therapy consisting of diaphragmatic breathing exercises and physiotherapy to relax tensed abdominal and thoracic muscles

Outcomes

Primary Outcome Measures

Change of self-perceived rumination frequency
Two point change of rumination frequency measured by the Rome IV questionnaire for adult functional gastrointestinal disorders, question 32. Scale 0-8, 0 = never, 8 = multiple times per day.

Secondary Outcome Measures

Change of abdominal pressure peaks measured by means of esophageal high-resolution manometry
No pancake-meal related abdominal pressure peaks of an amplitude of 30 mm Hg or higher indicating rumination.
Change in health-related quality of life
The 15D-questionnaire will be used for adults and the 16D-questionnaire for patients from 15 to 17 years old. 15D includes 15 dimensions: breathing, mental function, speech, vision, mobility, usual activities, vitality, hearing, eating, elimination, sleeping, distress, discomfort and symptoms, sexual activity, and depression, each scored from 1 (no problems) to 0 (being dead). The single index (15D score) on a 0-1 scale, representing the overall HRQoL, is calculated from the health state descriptive system by using a set of population-based preference or utility weights. 16D has been developed for adolescents aged 12-18 years. It includes 16 dimensions: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, school and hobbies, mental function, discomfort and symptoms, depression, distress, vitality, appearance, and friends, scored from 0 (min) to 1 (max). The single index (16D score) on a 0 1 scale, representing the overall HRQoL.
Change in functional capacity
Statistically significant change in the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) questionnaire in patients 18 years or older. WHODAS 2.0 covers 6 Domains of Functioning, including: Cognition - understanding & communicating Mobility- moving & getting around Self-care- hygiene, dressing, eating & staying alone Getting along- interacting with other people Life activities- domestic responsibilities, leisure, work & school Participation- joining in community activities The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed. As a result, the simple sum of the scores of the items across all domains constitutes a statistic that is sufficient to describe the degree of functional limitations.
Change in the depression score
Statistically significant change in the Beck Depression Inventory (BDI) questionnaire in patients 18 years or older. BDI is a 21-question multiple-choice self-report inventory for measuring the severity of depression. Each question had a set of at least four possible responses, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows: 0-9: indicates minimal depression, 10-18: indicates mild depression, 19-29: indicates moderate depression, and 30-63: indicates severe depression.
Change in the anxiety score
Statistically significant change in the Beck Anxiety Inventory (BAI) questionnaire in patients 18 years or older. The BAI contains 21 questions, each answer being scored on a scale value of 0 (not at all) to 3 (severely). Higher total scores indicate more severe anxiety symptoms. The standardized cutoffs are: 0-7: Minimal, 8-15: Mild, 16-25: Moderate, and 26-63: Severe.

Full Information

First Posted
January 29, 2022
Last Updated
February 28, 2023
Sponsor
Helsinki University Central Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05232097
Brief Title
Behavioral Therapy in Patients With Rumination
Official Title
Behavioral Therapy in Patients With Rumination
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Helsinki University Central Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study aim is to diagnose patients with the rumination syndrome defined by the Rome IV criteria and to treat them with behavioral therapy consisting of diaphragmatic breathing exercises and physiotherapy to relax tensed abdominal and thoracic muscles. Before referral to the study, gastroscopy, esophageal hgh-resolution manometry and 24-hour esophageal pH and impedance monitoring are required to rule out other esophageal conditions. Twenty Finnish speaking, 15-70 years old patients will be enrolled in this open study. All patients will visit the gastroenterologist at onset of the study and at 6 months. All patients will be referred to the speech therapist for five one-hour sessions consisting of diaphragmatic belching exercises and to the physiotherapist for two one-hour sessions consisting of exercises to relax tensed thoracic and abdominal muscles. All patients will also visit once the psychologist and dietician. Symptoms will be evaluated by the Rome IV questionnaire for adult functional gastrointestinal diseases at onset and at the 6-month control. Health-related quality of life, depression, anxiety, functional capacity will be evaluated by specific questionnaires at onset of the study and at the 6-month control. Esophageal high-resolution manometry will be performed at the 6-month control.
Detailed Description
Background: Rumination is a subconscious but a volitional, behavioral disorder. Contraction of the abdominal muscles results in an increase of abdominal pressure and a subsequent regurgitation of recently ingested food, followed by rechewing, reswallowing or spitting (1). The diagnosis is based on the Rome IV criteria for functional gastrointestinal disorders and esophageal high-resolution manometry (1, 2). Behavioral therapy consisting of diaphragmatic breathing exercises has proven efficient in these patients (3, 4). Psychophysical physiotherapy was effective in a published patient case (5). Aim: The study aim is to diagnose patients with rumination syndrome defined by the Rome IV criteria and to treat them with behavioral therapy. The primary aim is a reduction of two points ore more in the rumination frequency measured by the Rome IV questionnaire for adult functional gastrointestinal diseases (6). Secondary aims are improved esophageal high-resolution manometry, health-related quality of life, and functional capacity and reduced anxiety and depression scores. Patients: 20 Finnish speaking, 15-70 years old patients with rumination symptoms fulfilling the Rome IV criteria will be enrolled in this open study. Before referral to Helsinki University Central Hospital, gastroscopy, esophageal high-resolution manometry and esophageal 24-hour pH and impedance monitoring are required. Adolescents of 15 to 17 years old are referred to the childrens' gastroenterologist and adults 18 years or older are referred to the gastroenterologist. The inclusion criteria consist of rumination symtoms fulfilling the Rome IV criteria but esophageal high-resolution manometry may be negative because rumination cannot be always provoked during the study.The exclusion criteria comprise eating disorder, BMI <14, pregnancy, cognitive or other disorder that disallows behavioral therapy Methods: Symptoms will be evaluated by the Rome IV questionnaire for adult functional gastrointestinal diseases in all patients. Health-related quality of life will be evaluated by 15D, a 15-dimensional measure of health-related quality of life, depression by Beck Depression Inventory (BDI), anxiety by the Beck Anxiety Inventory (BAI), and functional capacity by WHODAS 2.0, World Health Organization disability assesment schedule 2.0 in the patients 18 years or older (7-10). In the patients 15-17 years old, health-related qualiy of life will be evaluated by 16D, a sixteen-dimensional health-related measure for adolescents (11). All questionnaires will be carried out at the onset of the study and at the 6-month control. Esophageal high-resolution manometry will be performed at the 6-month control. After the baseline visit to the gastroenterologist, patients will be sent to the speech therapist for five, one-hour sessions consisting of diaphragmatic breathing exercises and to a psychophysical physiotherapist for two one-hours sessions aiming at body-awareness to sense tensed thoracic and abdominal muscles and to relax them through guided exercises. Patients will continue these exercises at home during meals. All patient l visit the psychologist and dietician once to rule out eating disorders and other psychopathological conditions and will be referred to the psychiatrist when necessary. Esophageal high-resolution manometry will be performed at the 6-month control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Functional Gastrointestinal Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Behavioral therapy
Arm Type
Experimental
Arm Description
Behavioral therapy consisting of diaphragmatic breathing exercises and physiotherapy to relax tensed abdominal and thoracic muscles
Intervention Type
Behavioral
Intervention Name(s)
Behavioral therapy
Intervention Description
Diaphragmatic breathing exercises
Intervention Type
Behavioral
Intervention Name(s)
Physiotherapy
Intervention Description
Body awareness aiming at the patient becoming aware of the tensed thoracic and abdominal muscles and to reduce the tension by relaxation exercises taught by the psychophysical physiotherapist
Primary Outcome Measure Information:
Title
Change of self-perceived rumination frequency
Description
Two point change of rumination frequency measured by the Rome IV questionnaire for adult functional gastrointestinal disorders, question 32. Scale 0-8, 0 = never, 8 = multiple times per day.
Time Frame
Baseline and 6 months
Secondary Outcome Measure Information:
Title
Change of abdominal pressure peaks measured by means of esophageal high-resolution manometry
Description
No pancake-meal related abdominal pressure peaks of an amplitude of 30 mm Hg or higher indicating rumination.
Time Frame
6 months
Title
Change in health-related quality of life
Description
The 15D-questionnaire will be used for adults and the 16D-questionnaire for patients from 15 to 17 years old. 15D includes 15 dimensions: breathing, mental function, speech, vision, mobility, usual activities, vitality, hearing, eating, elimination, sleeping, distress, discomfort and symptoms, sexual activity, and depression, each scored from 1 (no problems) to 0 (being dead). The single index (15D score) on a 0-1 scale, representing the overall HRQoL, is calculated from the health state descriptive system by using a set of population-based preference or utility weights. 16D has been developed for adolescents aged 12-18 years. It includes 16 dimensions: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, school and hobbies, mental function, discomfort and symptoms, depression, distress, vitality, appearance, and friends, scored from 0 (min) to 1 (max). The single index (16D score) on a 0 1 scale, representing the overall HRQoL.
Time Frame
Baseline and 6 months
Title
Change in functional capacity
Description
Statistically significant change in the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) questionnaire in patients 18 years or older. WHODAS 2.0 covers 6 Domains of Functioning, including: Cognition - understanding & communicating Mobility- moving & getting around Self-care- hygiene, dressing, eating & staying alone Getting along- interacting with other people Life activities- domestic responsibilities, leisure, work & school Participation- joining in community activities The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed. As a result, the simple sum of the scores of the items across all domains constitutes a statistic that is sufficient to describe the degree of functional limitations.
Time Frame
Baseline and 6 months
Title
Change in the depression score
Description
Statistically significant change in the Beck Depression Inventory (BDI) questionnaire in patients 18 years or older. BDI is a 21-question multiple-choice self-report inventory for measuring the severity of depression. Each question had a set of at least four possible responses, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows: 0-9: indicates minimal depression, 10-18: indicates mild depression, 19-29: indicates moderate depression, and 30-63: indicates severe depression.
Time Frame
Baseline and 6 months
Title
Change in the anxiety score
Description
Statistically significant change in the Beck Anxiety Inventory (BAI) questionnaire in patients 18 years or older. The BAI contains 21 questions, each answer being scored on a scale value of 0 (not at all) to 3 (severely). Higher total scores indicate more severe anxiety symptoms. The standardized cutoffs are: 0-7: Minimal, 8-15: Mild, 16-25: Moderate, and 26-63: Severe.
Time Frame
Baseline and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Rome IV criteria for rumination syndrome fulfilled gastroscopy, esophageal HR-manometry and 24-hour pH-impedance monitoring performed before referral to study Exclusion Criteria: eating disorder, BMI <14, pregnancy, cognitive or other disorder that disallows behavioral therapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jari Punkkinen, Dr
Phone
+358 40 586 1044
Email
jari.punkkinen@hus.fi
First Name & Middle Initial & Last Name or Official Title & Degree
Perttu Arkkila, Prof
Phone
+358 50 4272272
Email
perttu.arkkila@hus.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jari Punkkinen, Dr
Organizational Affiliation
Helsinki University Central Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helsinki University Central Hospital
City
Helsinki
ZIP/Postal Code
00029
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jari Punkkinen, Dr
Phone
+358 40 5861044
Email
jari.punkkinen@hus.fi
First Name & Middle Initial & Last Name & Degree
Perttu Arkkila, Prof
Phone
+358 50 4272272
Email
perttu.arkkila@hus.fi
Facility Name
Helsinki University Hospital, Childrens' Hospital
City
Helsinki
ZIP/Postal Code
00029
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Satu Ruuska, Dr
Phone
+358 46 923 5966
Email
satu.ruuska@hus.fi
First Name & Middle Initial & Last Name & Degree
Riikka Gunnar, PhD
Phone
+358 50 427 0307
Email
riikka.gunnar@hus.fi

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29902642
Citation
Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome. Clin Gastroenterol Hepatol. 2018 Oct;16(10):1549-1555. doi: 10.1016/j.cgh.2018.05.049. Epub 2018 Jun 12.
Results Reference
background
PubMed Identifier
24366235
Citation
Kessing BF, Bredenoord AJ, Smout AJ. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol. 2014 Jan;109(1):52-9. doi: 10.1038/ajg.2013.428. Epub 2013 Dec 24.
Results Reference
background
PubMed Identifier
27185077
Citation
Barba E, Accarino A, Soldevilla A, Malagelada JR, Azpiroz F. Randomized, Placebo-Controlled Trial of Biofeedback for the Treatment of Rumination. Am J Gastroenterol. 2016 Jul;111(7):1007-13. doi: 10.1038/ajg.2016.197. Epub 2016 May 17.
Results Reference
background
PubMed Identifier
26661735
Citation
Halland M, Parthasarathy G, Bharucha AE, Katzka DA. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil. 2016 Mar;28(3):384-91. doi: 10.1111/nmo.12737. Epub 2015 Dec 10.
Results Reference
background
PubMed Identifier
26245059
Citation
Muurinen T, Walamies M. [Rumination in a young woman]. Duodecim. 2015;131(1):76-9. Finnish.
Results Reference
background
PubMed Identifier
27144634
Citation
Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao SS, Sperber A, Spiegel B, Tack J, Vanner S, Walker LS, Whorwell P, Yang Y. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016 Feb 13:S0016-5085(16)00180-3. doi: 10.1053/j.gastro.2016.02.014. Online ahead of print.
Results Reference
background
PubMed Identifier
8991972
Citation
Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996 Dec;67(3):588-97. doi: 10.1207/s15327752jpa6703_13.
Results Reference
background
PubMed Identifier
16005177
Citation
Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444-58. doi: 10.1016/j.janxdis.2005.05.004. Epub 2005 Jul 6.
Results Reference
background
PubMed Identifier
11491191
Citation
Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001 Jul;33(5):328-36. doi: 10.3109/07853890109002086.
Results Reference
background
PubMed Identifier
27820966
Citation
Federici S, Bracalenti M, Meloni F, Luciano JV. World Health Organization disability assessment schedule 2.0: An international systematic review. Disabil Rehabil. 2017 Nov;39(23):2347-2380. doi: 10.1080/09638288.2016.1223177. Epub 2016 Nov 7.
Results Reference
background
PubMed Identifier
8998489
Citation
Apajasalo M, Sintonen H, Holmberg C, Sinkkonen J, Aalberg V, Pihko H, Siimes MA, Kaitila I, Makela A, Rantakari K, Anttila R, Rautonen J. Quality of life in early adolescence: a sixteen-dimensional health-related measure (16D). Qual Life Res. 1996 Apr;5(2):205-11. doi: 10.1007/BF00434742.
Results Reference
background

Learn more about this trial

Behavioral Therapy in Patients With Rumination

We'll reach out to this number within 24 hrs